Ad is loading...
GGYPX
Price
$17.25
Change
-$0.07 (-0.40%)
Updated
Nov 15 closing price
VFIAX
Price
$542.50
Change
-$7.19 (-1.31%)
Updated
Nov 15 closing price
Ad is loading...

GGYPX vs VFIAX

Header iconGGYPX vs VFIAX Comparison
Open Charts GGYPX vs VFIAXBanner chart's image
Goldman Sachs Focused Value P
Price$17.25
Change-$0.07 (-0.40%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Admiral
Price$542.50
Change-$7.19 (-1.31%)
VolumeN/A
CapitalizationN/A
GGYPX vs VFIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GGYPX vs. VFIAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGYPX is a Buy and VFIAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.28T vs. GGYPX (58.4M). VFIAX (1.32) and GGYPX (1.29) have matching dividends . GGYPX was incepted earlier than VFIAX: GGYPX (7 years) vs VFIAX (24 years). GGYPX is a more actively managed with annual turnover of: 82.00 vs. VFIAX (2.00). GGYPX has a lower initial minimum investment than VFIAX: GGYPX (0) vs VFIAX (3000). GGYPX annual gain was more profitable for investors over the last year : 32.99 vs. VFIAX (30.22). VFIAX return over 5 years is better than : 88.12 vs. GGYPX (55.55).
GGYPXVFIAXGGYPX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years24 years-
Gain YTD22.16723.34795%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets58.4M1.28T0%
Annual Yield % from dividends1.291.3298%
Returns for 1 year32.9930.22109%
Returns for 3 years15.4524.9362%
Returns for 5 years55.5588.1263%
Returns for 10 yearsN/A187.71-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPLX47.020.62
+1.34%
Mplx LP
NAII4.53N/A
N/A
Natural Alternatives International
CMCO37.14-0.29
-0.77%
Columbus McKinnon Corp
ITOS8.23-0.23
-2.72%
iTeos Therapeutics
TDW50.73-2.46
-4.62%
Tidewater